Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether postoperatively oral treatment with high
dosis amiodarone for five days after intravenously admitted bolusinfusion will minimize the
risk for development of atrial fibrillation after coronary artery bypass grafting.